MECHANISMS OF RETROVIRUS-INDUCED NEURAL DYSFUNCTION
MECHANISMS OF RETROVIRUS-INDUCED NEURAL DYSFUNCTION
批准号:
3085332
负责人:
Steven W. Dow
金额:
$8.59万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-08-01 至 1994-07-31
关键词:
Retroviridae disease adrenocorticotropic hormone astrocytes cats feline leukemia /sarcoma virus immunocytochemistry immunofluorescence technique in situ hybridization nervous system disorder neurons neurotropic virus oligodendroglia pituitary gland somatotropin surface antigens tissue /cell culture virus infection mechanism virus morphology virus receptors
中文摘要
自从它们被鉴定为动物和其他动物的致病因子以来,
最近的人类,现在很明显,大多数逆转录病毒是
不同程度的嗜神经性。 逆转录病毒诱导
神经系统疾病,然而,目前都知之甚少,
研究兴趣浓厚的主题。 该项目旨在提供
为神经生物学和逆转录病毒学研究培训提供充分支持
让候选人史蒂文·W·道,调查机制,
逆转录病毒感染并改变神经细胞的功能。 调查
所提出的将利用体外和体内系统,
克隆的猫逆转录病毒(猫白血病病毒{FeLV}和猫
免疫缺陷病毒(FIV)开发研究逆转录病毒的模型-
诱发神经系统疾病。
第一阶段工作的具体目标是:(1)制定方法,
猫CNS细胞的原代培养和表征; 2)鉴定
逆转录病毒感染的中枢神经系统(CNS)靶细胞;和3)
使用体外和体内试验来识别和分析潜在的
嗜神经性逆转录病毒 将开发培养
三种主要神经细胞的富集群体:
星形胶质细胞、少突胶质细胞和神经元。 免疫细胞化学技术
将用于确定培养的时间进程和敏感性
猫CNS细胞暴露于体外猫逆转录病毒感染后,
无细胞病毒或病毒感染的单核细胞。 相关
体内研究将使用原位杂交和免疫细胞化学,
鉴定接种逆转录病毒的猫的CNS组织中的感染细胞。
猫逆转录病毒的潜在嗜神经性和/或神经毒性毒株
将检查它们感染和/或诱导
培养的猫中枢神经系统细胞的变化。
在第二阶段,这些调查将扩大到包括识别
中枢神经系统细胞表面受体介导逆转录病毒附着,
表征逆转录病毒诱导的神经细胞功能改变。
评估细胞功能改变的研究将包括
细胞表面表达改变的免疫细胞化学鉴定,
分化抗原在感染的神经胶质细胞,形态学研究,
神经元的存活和生长特征,以及
垂体激素分泌(垂体前叶细胞)。 体内研究,
在培训期间持续进行,将使体外和
猫逆转录病毒的体内嗜神经性
对培养的猫CNS细胞具有亲神经性也能够诱导
脑池内接种后猫的神经系统疾病。
英文摘要
Since their identification as disease-causing agents of animals and more
recently of humans, it is now apparent that most retroviruses are
neurotropic to varying degrees. Mechanisms by which retroviruses induce
neurologic disease are, however, currently both poorly understood and the
subject of intense research interest. This project is intended to provide
sufficient support for research training in neurobiology and retrovirology
to enable the candidate, Steven W. Dow, to investigate mechanisms by which
retroviruses infect and alter function of neural cells. The investigations
proposed will utilize both in vitro and in vivo systems and molecularly
cloned feline retroviruses (feline leukemia virus {FeLV} and feline
immunodeficiency virus {FIV}) to develop models for study of retrovirus-
induced neurologic disease.
The specific aims of Phase 1 of the work are: 1) to develop methods for
primary culture and characterization of feline CNS cells; 2) to identify
central nervous system (CNS) target cells for retrovirus infection; and 3)
to use in vitro and in vivo assays to identify and analyze potentially
neurotropic retroviruses. Techniques will be developed for culture of
enriched populations of the three major classes of neural cells:
astrocytes, oligodendrocytes, and neurons. Immunocytochemical techniques
will be used to identify the time course and susceptibility of cultured
feline CNS cells to feline retrovirus infection in vitro after exposure to
either cell-free virus or to virus-infected mononuclear cells. Correlative
in vivo studies will use in situ hybridization and immunocytochemistry to
identify infected cells in CNS tissues of retrovirus-inoculated cats.
Potentially neurotropic and/or neurovirulent strains of feline retroviruses
will be examined for their differential ability to infect and/or induce
alterations in cultured feline CNS cells.
In Phase 2, these investigations will be extended to include identification
of CNS cell surface receptors that mediate retrovirus attachment and to
characterize retrovirus-induced alterations in neural cell function.
Studies to evaluate alterations in cell function will include
immunocytochemical identification of altered expression of cell surface and
differentiation antigens in infected glial cells, morphologic studies of
survival and outgrowth characteristics of neurons, and measurement of
pituitary hormone secretion (anterior pituitary cells). In vivo studies,
to be ongoing during the training period, will correlate the in vitro and
in vivo neurotropism of feline retroviruses by determining whether viruses
that are neurotropic for cultured feline CNS cells are also able to induce
neurologic disease in cats after intracisternal inoculation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma
-
批准号:10488605
-
项目类别:
-
资助金额:$55.22万
-
财政年份:2017
-
负责人:Steven W. Dow
-
依托单位:
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma
-
批准号:10260606
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Steven W. Dow
-
依托单位:
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma
-
批准号:10247894
-
项目类别:
-
资助金额:$55.33万
-
财政年份:2017
-
负责人:Steven W. Dow
-
依托单位:
Mechanisms of Enteric Burkholderia psuedomallei infection
-
批准号:8207208
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2011
-
负责人:Steven W. Dow
-
依托单位:
Mechanisms of Enteric Burkholderia psuedomallei infection
-
批准号:8028304
-
项目类别:
-
资助金额:$18.07万
-
财政年份:2011
-
负责人:Steven W. Dow
-
依托单位:
Mucosal immunization for cross-protection against pneumonic burkholderia
-
批准号:8261421
-
项目类别:
-
资助金额:$22.23万
-
财政年份:2011
-
负责人:Steven W. Dow
-
依托单位:
Mucosal immunization for cross-protection against pneumonic burkholderia
-
批准号:7675566
-
项目类别:
-
资助金额:$21.49万
-
财政年份:2009
-
负责人:Steven W. Dow
-
依托单位:
Innate Immunity to Pneumonic Burkholderia Infection
-
批准号:7641020
-
项目类别:
-
资助金额:$25.53万
-
财政年份:2008
-
负责人:Steven W. Dow
-
依托单位:
Innate Immunity to Pneumonic Burkholderia Infection
-
批准号:7126628
-
项目类别:
-
资助金额:$21.64万
-
财政年份:2005
-
负责人:Steven W. Dow
-
依托单位:
Antigen Presentation and Pulmonary Immunity to Plague
-
批准号:6788190
-
项目类别:
-
资助金额:$42.83万
-
财政年份:2003
-
负责人:Steven W. Dow
-
依托单位:
Antigen Presentation and Pulmonary Immunity to Plague
-
批准号:6861718
-
项目类别:
-
资助金额:$44.12万
-
财政年份:2003
-
负责人:Steven W. Dow
-
依托单位:
Antigen Presentation and Pulmonary Immunity to Plague
-
批准号:7009628
-
项目类别:
-
资助金额:$44.21万
-
财政年份:2003
-
负责人:Steven W. Dow
-
依托单位:
Antigen Presentation and Pulmonary Immunity to Plague
-
批准号:6689421
-
项目类别:
-
资助金额:$25.89万
-
财政年份:2003
-
负责人:Steven W. Dow
-
依托单位:
TUMOR ANGIOGENESIS INHIBITIION BY SYSTEMIC GENE DELIVERY
-
批准号:6131623
-
项目类别:
-
资助金额:$16.48万
-
财政年份:2000
-
负责人:Steven W. Dow
-
依托单位:
TUMOR ANGIOGENESIS INHIBITIION BY SYSTEMIC GENE DELIVERY
-
批准号:6613763
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2000
-
负责人:Steven W. Dow
-
依托单位:
TUMOR ANGIOGENESIS INHIBITIION BY SYSTEMIC GENE DELIVERY
-
批准号:6377876
-
项目类别:
-
资助金额:$0.99万
-
财政年份:2000
-
负责人:Steven W. Dow
-
依托单位:
TUMOR ANGIOGENESIS INHIBITIION BY SYSTEMIC GENE DELIVERY
-
批准号:6792174
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2000
-
负责人:Steven W. Dow
-
依托单位:
TUMOR ANGIOGENESIS INHIBITIION BY SYSTEMIC GENE DELIVERY
-
批准号:6548020
-
项目类别:
-
资助金额:$16.31万
-
财政年份:2000
-
负责人:Steven W. Dow
-
依托单位:
TUMOR ANGIOGENESIS INHIBITIION BY SYSTEMIC GENE DELIVERY
-
批准号:6522604
-
项目类别:
-
资助金额:$28.37万
-
财政年份:2000
-
负责人:Steven W. Dow
-
依托单位:
MECHANISMS OF RETROVIRUS-INDUCED NEURAL DYSFUNCTION
-
批准号:3085333
-
项目类别:
-
资助金额:$8.59万
-
财政年份:1989
-
负责人:Steven W. Dow
-
依托单位:
海外基金